Explore

Trendline Trendline
Viridian Therapeutics to Engage in June 2026 Investor Conferences, Highlighting Autoimmune and Rare Disease Focus

Viridian Therapeutics to Engage in June 2026 Investor Conferences, Highlighting Autoimmune and Rare Disease Focus

Viridian Therapeutics to Engage in June 2026 Investor Conferences, Highlighting Autoimmune and Rare Disease Focus
Trendline Trendline
Ollin Biosciences to Engage in Key Investor Conferences for Vision Therapies

Ollin Biosciences to Engage in Key Investor Conferences for Vision Therapies

Ollin Biosciences to Engage in Key Investor Conferences for Vision Therapies
Trendline Trendline
Ollin Biosciences to Participate in June 2026 Investor Conferences, Highlighting Vision-Therapy Innovations

Ollin Biosciences to Participate in June 2026 Investor Conferences, Highlighting Vision-Therapy Innovations

Ollin Biosciences to Participate in June 2026 Investor Conferences, Highlighting Vision-Therapy Innovations
Trendline Trendline
Viridian Therapeutics to Engage Investors at June 2026 Conferences, Highlighting Biotech Innovations

Viridian Therapeutics to Engage Investors at June 2026 Conferences, Highlighting Biotech Innovations

Viridian Therapeutics to Engage Investors at June 2026 Conferences, Highlighting Biotech Innovations
Trendline Trendline
Verastem Oncology to Present at Jefferies Healthcare Conference 2026

Verastem Oncology to Present at Jefferies Healthcare Conference 2026

Verastem Oncology to Present at Jefferies Healthcare Conference 2026
Trendline Trendline
Exelixis to Present at Major Healthcare Conferences, Highlighting Oncology Innovations

Exelixis to Present at Major Healthcare Conferences, Highlighting Oncology Innovations

Exelixis to Present at Major Healthcare Conferences, Highlighting Oncology Innovations
Trendline Trendline
Ollin Biosciences to Engage Investors at June 2026 Conferences

Ollin Biosciences to Engage Investors at June 2026 Conferences

Ollin Biosciences to Engage Investors at June 2026 Conferences
Trendline Trendline
TOBY's Urine-Based Alzheimer's Test Gains FDA Breakthrough Designation

TOBY's Urine-Based Alzheimer's Test Gains FDA Breakthrough Designation

TOBY's Urine-Based Alzheimer's Test Gains FDA Breakthrough Designation
Trendline Trendline
Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress

Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress

Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress
Trendline Trendline
Silence Therapeutics to Present at Jefferies Global Healthcare Conference 2026

Silence Therapeutics to Present at Jefferies Global Healthcare Conference 2026

Silence Therapeutics to Present at Jefferies Global Healthcare Conference 2026
Trendline Trendline
Micron Biomedical Appoints New CFO to Advance Needle-Free Vaccine Technology

Micron Biomedical Appoints New CFO to Advance Needle-Free Vaccine Technology

Micron Biomedical Appoints New CFO to Advance Needle-Free Vaccine Technology
Trendline Trendline
GSK and Ionis Achieve Breakthrough in Hepatitis B Treatment with Bepirovirsen

GSK and Ionis Achieve Breakthrough in Hepatitis B Treatment with Bepirovirsen

GSK and Ionis Achieve Breakthrough in Hepatitis B Treatment with Bepirovirsen